SHARECARE, INC. Accounts Receivable, Credit Loss Expense (Reversal)
SHARECARE, INC. reported Accounts Receivable, Credit Loss Expense (Reversal) of $188.00 thousand for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ProvisionForDoubtfulAccounts · last filed 2024-08-09
- SHARECARE, INC. accounts receivable, credit loss expense (reversal) for the quarter ending 2024-06-30 was $188.00K, a 82.83% decline year-over-year.
- SHARECARE, INC. accounts receivable, credit loss expense (reversal) for the quarter ending 2024-03-31 was $411.00K, a 78.01% decline year-over-year.
- SHARECARE, INC. accounts receivable, credit loss expense (reversal) for the quarter ending 2023-12-31 was $212.00K, a 71.43% decline year-over-year.
- SHARECARE, INC. accounts receivable, credit loss expense (reversal) for the quarter ending 2023-09-30 was $724.00K, a 4.11% decline year-over-year.
- SHARECARE, INC. accounts receivable, credit loss expense (reversal) for fiscal 2023 was $3.02M, a 5.83% decline from fiscal 2022.
- SHARECARE, INC. accounts receivable, credit loss expense (reversal) for fiscal 2022 was $3.21M, a 5.98% increase from fiscal 2021.
- SHARECARE, INC. accounts receivable, credit loss expense (reversal) for fiscal 2021 was $3.03M, a 44.66% decline from fiscal 2020.
- SHARECARE, INC. accounts receivable, credit loss expense (reversal) for fiscal 2020 was $5.47M.
| Period end | Accounts Receivable, Credit Loss Expense (Reversal) 3 month | Accounts Receivable, Credit Loss Expense (Reversal) 6 month | Accounts Receivable, Credit Loss Expense (Reversal) 9 month | Accounts Receivable, Credit Loss Expense (Reversal) 12 month |
|---|---|---|---|---|
| 2024-06-30 | $188.00K 10-Q · filed 2024-08-09 | $597.00K 10-Q · filed 2024-08-09 | $811.00K derived: sum of 3 quarters · filed 2024-08-09 | $1.53M derived: sum of 4 quarters · filed 2024-08-09 |
| 2024-03-31 | $411.00K 10-Q · filed 2024-05-09 | $623.00K derived: sum of 2 quarters · filed 2024-05-09 | $1.35M derived: sum of 3 quarters · filed 2024-05-09 | $2.44M derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-12-31 | $212.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $936.00K derived: sum of 2 quarters · filed 2024-03-29 | $2.03M derived: sum of 3 quarters · filed 2024-08-09 | $3.02M 10-K · filed 2024-03-29 |
| 2023-09-30 | $724.00K 10-Q · filed 2023-11-09 | $1.82M derived: sum of 2 quarters · filed 2024-08-09 | $2.81M 10-Q · filed 2023-11-09 | $4.43M derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-06-30 | $1.09M 10-Q · filed 2024-08-09 | $2.08M 10-Q · filed 2024-08-09 | $3.71M derived: sum of 3 quarters · filed 2024-08-09 | $4.46M derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | $1.87M 10-Q · filed 2024-05-09 | $2.61M derived: sum of 2 quarters · filed 2024-05-09 | $3.37M derived: sum of 3 quarters · filed 2024-05-09 | $4.43M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $742.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $1.50M derived: sum of 2 quarters · filed 2024-03-29 | $2.56M derived: sum of 3 quarters · filed 2024-03-29 | $3.21M 10-K · filed 2024-03-29 |
| 2022-09-30 | $755.00K 10-Q · filed 2023-11-09 | $1.82M derived: sum of 2 quarters · filed 2023-11-09 | $2.47M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $1.06M 10-Q · filed 2023-08-09 | $1.71M 10-Q · filed 2023-08-09 | ||
| 2022-03-31 | $650.00K 10-Q · filed 2023-05-10 | |||
| 2021-12-31 | $3.03M 10-K · filed 2023-03-31 | |||
| 2020-12-31 | $5.47M 10-K · filed 2022-03-31 |